Cancer Immunotherapy Trial Individualizes Therapy

Clinical trials at UC San Diego Health: health.ucsd.edu/clinicaltrials

Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing has successfully eradicated the disease. As a last-ditch effort to halt growth, Thurman was referred to a personalized cancer therapy trial being developed at Moores Cancer Center at UC San Diego Health. The clinical trial, a collaboration between UC San Diego and La Jolla Institute for Immunology researchers, employs an investigational cell therapy that uses a patient’s own immune cells — specifically tumor-infiltrating lymphocytes (TIL) — to seek and destroy their own unique cancer cells.

More information about Cancer Care at UC San Diego Health: health.ucsd.edu/care/cancer/

More information about Immunotherapy at UC San Diego Health:
health.ucsd.edu/care/cancer/treatments/immunothera…

0:00 Cancer Immunotherapy Trial
0:17 Bernard's journey
1:00 Tumor infiltrating lymphocytes
1:50 How it works
2:28 Individualized therapy